EGF and Parkinson disease: Our analysis showed that serum EGF levels in the PD patients were significantly higher than those in the healthy controls, and with the progression of the disease, EGF levels gradually decreased and serum EGF levels in the PD patients were negatively correlated with UPDRS III scores.